Print

Print


http://www.marketwatch.com/story/neuroderm-announces-start-of-phase-2a-study-of-continuous-subcutaneous-liquid-levodopacarbidopa-administration-for-patients-with-severe-parkinsons-disease-2014-09-03
Ray
Rayilyn Brown
Past Director AZNPF
Arizona Chapter National Parkinson Foundation

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn